Can-Fite BioPharma CANF
NYSE CANF
$1.58 -0.08 (-4.89%)
As of: Nov 11, 2026 · 1:48 PM EST

Can-Fite BioPharma (CANF) Price to Earnings (2016 - 2020)

Updated

Can-Fite BioPharma's (CANF) Price to Earnings was 563.33 for Q4 2020, up 171.3% from 207.65 a year earlier and up 322.7% from the prior quarter.

Analysis

Can-Fite BioPharma (CANF) Price to Earnings (2016 - 2020) Analysis & Trends

For FY2019, Price to Earnings at Can-Fite BioPharma was 207.65, down 64.3% from FY2018.

  • Price to Earnings has declined for seven consecutive years.
  • By year, Price to Earnings came in at 581.00 in FY2018 (-0.3%), 583.03 in FY2017 (-2.6%), 598.66 in FY2016 (-99.8%) and 285199.35 in FY2015 (-10.9%).
  • The Q4 2020 figure ranks as the highest quarterly Price to Earnings since Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Can-Fite BioPharma 2.16 Mn -17.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 563.33
Sep 30, 2020 133.27
Jun 30, 2020 309.29
Dec 31, 2019 207.65
Sep 30, 2017 452.27
Jun 30, 2017 421.94
Mar 31, 2017 792.44
Dec 31, 2016 598.66
API Access

Can-Fite BioPharma Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CANF&period=max&api_key=YOUR_API_KEY